3D Ultrasound - Based Hysteroscopy Versus Virtual Hysteroscopy
Launched by HOPITAL FOCH · Feb 8, 2013
Trial Information
Current as of May 18, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Diagnostic hysteroscopy prescribed either for a case of infertility or in case of doubt of endometrial / uterine pathology suspected by ultrasound or hysterography.
- Exclusion Criteria:
- • Current Pregnancy.
- • Genital infection
About Hopital Foch
Hospital Foch is a leading healthcare institution located in Suresnes, France, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, Hospital Foch actively engages in the development of new therapeutic approaches across various medical disciplines, facilitating cutting-edge studies that aim to enhance treatment outcomes and improve patient quality of life. With a multidisciplinary team of experienced researchers and healthcare professionals, the hospital fosters a collaborative environment that prioritizes ethical standards and scientific rigor, ensuring the highest quality in clinical trial execution and patient safety.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Suresnes, , France
Patients applied
Trial Officials
Stéphanie FAY, MD
Study Chair
Hôpital FOCH 40, rue Worth 92150 Suresnes
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials